We invest in medical biotechnology companies at the most value-creating stage.
Biotech is a compelling investment because it solves significant global health challenges.
We build biotech companies from breakthrough research — based on world-class Scandinavian science and structured for commercial success.
World-class research becomes world-class biotech companies.
We systematically de-risk each project before investment, sourcing from leading Scandinavian universities and applying 12–24 months of structured scientific and commercial validation.
When we invest, the company is de-risked — with a focused plan, capable team, and a shorter path to exit.
Our team brings senior experience from science, pharma, and institutional investment — with financial and operational depth rarely found in medical biotech.
We design the plan and build the company together with the scientists, provide the capital — and execute, from start to exit.
Our portfolio companies are focused purely on drug development — each with a clearly defined development plan and a clear path to pharma acquisition.
We offer professional and institutional investors structured access to biotech companies built on rigorous science and commercial readiness.
FSA Registration
• Marigold Investment Management is registered under the AIFM framework (FTID: 23321)
• Marigold Maturation Fund is registered under the AIF framework (FTID: 25657)
What We Do
We co-found, validate, and mature companies with academic inventors — and prepare them for their next owner:
an international pharma company capable of bringing breakthrough medicines to market.
Many groundbreaking inventions could become life-changing medicines — but are never developed, and never reach the patients they could have helped.
Often, this is because academic inventors lack access to the capabilities and capital needed to bring their science to market.
Marigold Investment Management is built to change that.
Company Details
- Employees
- 7
- Founded
- -
- Address
- Agern Alle 24, Hørsholm,capital Region 2970,denmark
- Industry
- Investment Management
- NAICS
-
Other Financial Investment ActivitiesPortfolio ManagementAll Other Financial Investment ActivitiesTrust, Fiduciary, and Custody ActivitiesMiscellaneous Financial Investment Activities
- Website
- http://www.mgim.dk
- Keywords
- Life Science, Co-founding, Company Creation, Biotech, Drug Development, Venture Capital, Startups, Scaleups, Innovation, Entrepreneurship, Spin Out, Research, Go-to-market, Intellectual Property, IPR, Strategy, Financing, Venture Creation, Medtech.
- HQ
- Hørsholm, Capital Region
Marigold Investment Management Questions
Marigold Investment Management's website is http://www.mgim.dk
Marigold Investment Management's LinkedIn profile is https://dk.linkedin.com/company/marigold-investment
Marigold Investment Management has
7 employees.
View email and phone details for 7
employees at Marigold Investment Management.
Marigold Investment Management's industry is
Investment Management
Marigold Investment Management's top competitors are
Zenit Science,
Precision Immunotherapy Alliance, Prima,
Neotargets Ab,
Oncosync,
Kripthonite Therapeutics,
Zyneyro,
Clexbio,
Cresco - Centre For Embryology And Healthy Development,
Scitribe,
Nyt Om Navne - Investor Relations @hca.
Marigold Investment Management's categories are Investment Management
Marigold Investment Management's founding year is 2024
